Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-16T21:41:32.996Z Has data issue: false hasContentIssue false

Vancomycin-Resistant Enterococci in Long-Term Care Facilities

Published online by Cambridge University Press:  02 January 2015

Shmuel Benenson*
Affiliation:
Department of Clinical Microbiology and Infectious Diseases, Jerusalem, Israel
Matan J. Cohen
Affiliation:
Center for Quality and Safety, Jerusalem, Israel
Colin Block
Affiliation:
Department of Clinical Microbiology and Infectious Diseases, Jerusalem, Israel
Sagit Stern
Affiliation:
Hadassah-Hebrew University, Jerusalem, Israel
Yuval Weiss
Affiliation:
Hadassah-Hebrew University Medical Center, Jerusalem, Israel
Allon E. Moses
Affiliation:
Department of Clinical Microbiology and Infectious Diseases, Jerusalem, Israel
*
Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University Medical Center, POB 12000, Jerusalem 91120, Israel( benenson@hadassah.org.il)

Abstract

Knowledge of the prevalence rates and associated risk markers of vancomycin-resistant enterococci (VRE) colonization among long-term care facility (LTCF) residents could be used to improve screening policies among newly admitted hospital inpatients. In a cross-sectional survey among 1,215 residents of LTCFs in Jerusalem, the VRE carriage rate was 9.6%. Previous hospitalization and antibiotic treatment were associated with elevated VRE colonization rate. In contrast, moderate and severe levels of dependency and prolonged stay, in an LTCF were associated with a decrease in the VRE colonization rate.

Information

Type
Concise Communications
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable